Clinical Trials Directory

Trials / Completed

CompletedNCT01638143

Bio-equivalence Study

Comparison of Bioavailability of Three Different Vitamin K2 Formulations

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study is to compare absorption of vitamin K2 (menaquinone-7) after intake of three different vitamin K2 supplements.

Detailed description

Several manufacturers are producing vitamin K2 raw material in different forms, namely oil and powder. To ensure bioequivalence of different vitamin K2 sources, the investigators are interested to compare the bioavailability of three different vitamin K2 formulations that are already commercially available. Two different oils and one powder product will be compared in this randomized cross-over trial. The investigators hypothesize that different vitamin K2 sources give no differences in bioavailability of vitamin K2.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMenaQ7 M-1500 capsulesThe study participants will receive three different types of capsules as a single dose (75 μg of MK-7/day): * MenaQ7 M-1500 capsule * Gnosis P-1000 capsule * Gnosis M-1500 capsule Every two weeks, participants switch to another type of capsule; the washout period will therefore be two weeks.
DIETARY_SUPPLEMENTGnosis P-1000 capsulesThe study participants will receive three different types of capsules as a single dose (75 μg of MK-7/day): * MenaQ7 M-1500 capsule * Gnosis P-1000 capsule * Gnosis M-1500 capsule Every two weeks, participants switch to another type of capsule; the washout period will therefore be two weeks.
DIETARY_SUPPLEMENTGnosis M-1500 capsulesThe study participants will receive three different types of capsules as a single dose (75 μg of MK-7/day): * MenaQ7 M-1500 capsule * Gnosis P-1000 capsule * Gnosis M-1500 capsule Every two weeks, participants switch to another type of capsule; the washout period will therefore be two weeks.

Timeline

Start date
2010-11-01
Primary completion
2011-01-01
Completion
2011-08-01
First posted
2012-07-11
Last updated
2012-07-11

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01638143. Inclusion in this directory is not an endorsement.